Compare Regeneron Pharmaceuticals Inc (REGN) vs Ishares Msci Thailand Etf (THD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Regeneron Pharmaceuticals Inc vs Ishares Msci Thailand Etf — how do they compare? Regeneron Pharmaceuticals Inc trades at $652.76 (market cap $70.79B), while Ishares Msci Thailand Etf trades at $72.92. The key difference: Regeneron Pharmaceuticals Inc pays a 0.56% dividend while Ishares Msci Thailand Etf pays none, and Ishares Msci Thailand Etf is trading nearer its 52-week high, Regeneron Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| REGN | THD | |
|---|---|---|
Market Cap | $70.79B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $812.27 | $75.05 |
52-Week Low | $545.46 | $55.83 |
Enterprise Value | $64.74B | — |
Dividend Yield | 0.56% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Regeneron Pharmaceuticals (REGN) trades at $675.19, down 0.22% on the day, with a bullish technical signal from moving averages. The company shows strong fundamentals with a P/E of 16.41, net income margin of 29.65%, and consistent earnings beats in recent quarters. However, sentiment is clouded by a securities class action lawsuit related to a Phase 3 clinical trial failure disclosed in July 2026.
The outlook remains positive based on analyst consensus with a $764.50 price target and 69% buy ratings, but near-term volatility is likely due to legal overhangs. Investment opportunity lies in robust profitability and growth prospects, while key risks include litigation outcomes and clinical trial setbacks.
THD trades at $73.02, up 0.21% on the day, with a bullish technical outlook supported by moving averages, though the 6-day RSI indicates overbought conditions. The stock lacks disclosed fundamental ratios, but recent dividend activity includes a $1.71 per share payment scheduled for June 2026. News highlights THD's strong performance among ASEAN ETFs, driven by exposure to AI hardware plays like Delta Electronics.
Outlook is cautiously optimistic given technical strength and AI-driven tailwinds, but risks include concentrated holdings and profit-taking vulnerability. Investors should weigh the bullish trend against high RSI levels and reliance on specific sectors for future gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →About Ishares Msci Thailand Etf
THD is a country-specific ETF that tracks the performance of the Thai equity market. It provides broad exposure to Thailand's economy across sectors like electronics, energy, and financials, with top holdings such as Delta Electronics.
Read more on THD →
